Close

Form 8-K KEMET CORP For: Nov 29

November 29, 2016 9:02 AM EST


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): November 29, 2016

KEMET Corporation
(Exact name of registrant as specified in its charter)

Delaware
 
001-15491
 
57-0923789
(State of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)

2835 KEMET Way, Simpsonville, SC
 
29681
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code:  (864) 963-6300

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))







Item 7.01                                           Regulation FD Disclosure

Per Loof, KEMET's Chief Executive Officer and William M. Lowe, Jr., Executive Vice President and Chief Financial Officer, of KEMET Corporation (the “Company”), are scheduled to provide certain investor information, including an investor presentation commencing on Tuesday, November 29, 2016, in Boca Raton, Florida at 2:50 pm eastern standard time. The slide package prepared by the Company for use in connection with this presentation is furnished herewith as Exhibit 99.1. All of the information in the attached slide package is presented as of November 29, 2016, and the Company does not assume any obligation to update such information in the future.

The information included in this Form 8-K, as well as the exhibit referenced herein, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits

(a.)                              Not Applicable

(b.)                              Not Applicable

(c.)                               Not Applicable

(d.)                              Exhibits


Exhibit No.
 
Description of Exhibit
 
 
 
99.1
 
 
Slide package prepared for use by Mr. Loof and Mr. Lowe in connection with an investor presentation commencing on Tuesday November 29, 2016.






SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.




Dated: November 29, 2016
 
 
 
 
 
 
KEMET CORPORATION
 
 
 
 
 
 
By:
/s/ WILLIAM M. LOWE, JR.
 
 
William M. Lowe, Jr.
 
 
Executive Vice President and
Chief Financial Officer









INDEX TO EXHIBITS


Exhibit No.
 
Description of Exhibit
 
 
 
99.1
 
Slide package prepared for use by Mr. Loof and Mr. Lowe in connection with an investor presentation commencing on Tuesday November 29, 2016.



1 Bank of America Leveraged Finance Conference November 29, 2016 Presenters: Per Loof – Chief Executive Officer William M. Lowe, Jr. EVP & Chief Financial Officer


 
2 Cautionary Statement Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about KEMET Corporation's (the "Company") financial condition and results of operations that are based on management's current expectations, estimates, and projections about the markets in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates," variations of such words, and other similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise. Factors that may cause the actual outcomes and results to differ materially from those expressed in, or implied by, these forward- looking statements include, but are not necessarily limited to the following: (i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate; (ii) continued net losses could impact our ability to realize current operating plans and could materially adversely affect our liquidity and our ability to continue to operate; (iii) adverse economic conditions could cause the write down of long-lived assets or goodwill; (iv) an increase in the cost or a decrease in the availability of our principal or single-sourced purchased materials; (v) changes in the competitive environment; (vi) uncertainty of the timing of customer product qualifications in heavily regulated industries; (vii) economic, political, or regulatory changes in the countries in which we operate; (viii) difficulties, delays or unexpected costs in completing the restructuring plans; (ix) equity method investment in NEC TOKIN exposes us to a variety of risks; (x) possible acquisition of NEC TOKIN may not achieve all of the anticipated results; (xi) acquisitions and other strategic transactions expose us to a variety of risks; (xii) our business could be negatively impacted by increased regulatory scrutiny and litigation; (xiii) inability to attract, train and retain effective employees and management; (xiv) inability to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (xv) exposure to claims alleging product defects; (xvi) the impact of laws and regulations that apply to our business, including those relating to environmental matters; (xvii) the impact of international laws relating to trade, export controls and foreign corrupt practices; (xviii) volatility of financial and credit markets affecting our access to capital; (xix) the need to reduce the total costs of our products to remain competitive; (xx) potential limitation on the use of net operating losses to offset possible future taxable income; (xxi) restrictions in our debt agreements that limit our flexibility in operating our business; (xxii) failure of our information technology systems to function properly or our failure to control unauthorized access to our systems may cause business disruptions; (xxiii) additional exercise of the warrant by K Equity which could potentially result in the existence of a significant stockholder who could seek to influence our corporate decisions; and (xxiv) fluctuation in distributor sales could adversely affect our results of operations.


 
3 Company Overview • Global manufacturer of tantalum, multilayer ceramic, solid and electrolytic, aluminum and film and paper capacitors • 17 manufacturing plants located in North America, Europe and Asia • 9,185 employees worldwide (September 30, 2016) – USA 623 Mexico 5,027 – Asia 2,003 Europe 1,532 • Recognized as the “Easy to buy from Company” (ETBF) and “Easy to design in” (E2Di) • LTM 9/30/16 Revenues and EBITDA of $733 million and $97.8 million, respectively Simpsonville Ciudad Victoria, Monterrey & Matamoros, Mexico Evora, Portugal Pontecchio, Italy Kyustendil, Bulgaria Anting-Shanghai, China Carson City, NV Batam, Indonesia Suomussalmi, Finland Granna & Farjestaden, Sweden Suzhou, China Skopje, Macedonia


 
4 Product Overview Solid Capacitor Business Group Tantalum & Ceramics Product Lines Film & Electrolytic Business Group LTM Sales (9/30/16) $560mm (76%) $173mm (24%) Market Segment / Selected Application Detail • Computer – Microprocessor Decoupling • Telecommunications – Transceiver Cards • Mobile Phones – Audio & Battery Backup • Gaming – Processor Decoupling • LCD TV – Video Converter • Automotive – Engine Control/Safety • Military/Aerospace – Avionics/Comm • Industrial – Motor Start & Drives • Automotive – HID Lighting/Engine Ctrl • Renewable Energy – Power Inverters • Industrial – Power Factor Correction • Consumer/Industrial – Power Supplies Market Demand • Tantalum: high reliability and high capacitance. (Tablets / laptops and high reliability applications) • Ceramic: smaller capacitance and smaller sizes – Focus on higher margin specialty industries (defense, aerospace automobile, downhole drilling, medical telecom) • DC Film: Focus Household items (power supplies / smoke detectors / thermostats) connected to the internet and interact with wireless handsets - “Internet of Things”


 
Military & Aerospace Medical Industrial Computer Automotive Consumer Market Segments


 
Automotive Electronics


 
Where are our parts used? Drivetrain example Fuel Pump Speed Sensor Rectifier Inverter Motor Drive ERS TCU Power Steering Throttle Sensor O2 Sensor Direct Injection Traction Control ECU


 
Where are our parts used? Safety example Power Window Backup Backup Camera TPMS Air Bags Steering Torque Control Crash Avoidance / Lane Detection Adaptive Headlights


 
Where are our parts used? Infotainment example Infotainment Module Cluster CAN Controller Body Control Module


 
105 customer meetings 7 product & capability launches 11 interviews with industry press


 
Looking Ahead


 
Next 10 years Major Drivers More Personal Smartphone, TVs, Medical, Consumer Devices, PCs Big Data Computer, Communication, Medical Infrastructure Energy Efficiency Automotive, Industrial, Consumer Uberization Seamless Digital Experience


 
What Comes Next? Intelligent Assistance 5 ni.com The Industrial Internet of Things Image Recognition Augmented & Virtual Reality Internet of Things


 
What Comes Next? Computer Assisted Health Care Autonomous Drones New Semiconductor Technologies • GaN (Gallium Nitride) • SiC (Silicon Carbide) Autonomous Vehicles


 
“Uberization of KEMET” Seamless Digital Experience


 
Search Simulation Tools Educating Engineers Social Media Mobile Apps Analytics


 
Live Distributor Price & Availability Dielectric Agnostic Multiple Points of Entry Filter Driven Live Distributor Price & Availability New Innovative & Proprietary Search Engine


 
Designed by Engineers for Engineers


 
Simulation Tool


 
2330 Engineers @ 132 sessions in FY16


 
Anywhere, Anytime


 
Tantalum Capacitors New technologies drive passive component industry volume growth, capacity utilization, price stabilization and increased profitability Ceramic Capacitors Film Capacitors Aluminum Capacitors EMI Devices


 
Summary Financial Information


 
FY16 Q2 & FY17 Q2 Comparison U.S. GAAP (Unaudited) 24 For the Quarters Ended (Amounts in thousands, except percentages and per share data) Sep 2016 Jun 2016 Sep 2015 Net sales $ 187,308 $ 184,935 $ 186,123 Gross margin $ 46,413 $ 42,523 $ 42,806 Gross margin as a percentage of net sales 24.8 % 23.0 % 23.0 % Selling, general and administrative $ 25,972 $ 25,914 $ 22,948 SG&A as a percentage of net sales 13.9 % 14.0 % 12.3 % Operating income (loss) (1)(2) $ 3,050 $ 8,898 $ 13,987 Operating margin as a percentage of net sales 1.6 % 4.8 % 7.5 % Net income (loss) from continuing operations (1)(2) $ (4,998 ) $ (12,205 ) $ 7,194 (1) Includes non-cash (gain) loss due to the change in the put option value of $(1.6) million, $12.0 million and $(2.2) million for the quarters ended September 30, 2016, June 30, 2016 and September 30, 2015, respectively. (2) Includes write down of long-lived assets and restructuring charges of $10.2 million for the quarter ended September 30, 2016.


 
FY16 Q2 & FY17 Q2 Comparison Non-GAAP (Unaudited) 25 For the Quarters Ended (Amounts in thousands, except percentages and per share data) Sep 2016 Jun 2016 Sep 2015 Net sales $ 187,308 $ 184,935 $ 186,123 Adjusted gross margin $ 46,833 $ 43,215 $ 43,452 Adjusted gross margin as a percentage of net sales 25.0 % 23.4 % 23.3 % Adjusted selling, general and administrative $ 22,475 $ 21,980 $ 21,130 Adjusted SG&A as a percentage of net sales 12.0 % 11.9 % 11.4 % Adjusted operating income (loss) $ 17,291 $ 14,362 $ 16,230 Adjusted operating income (loss) as a percentage of net sales 9.2 % 7.8 % 8.7 % Adjusted net income (loss) $ 6,955 $ 3,306 $ 4,274 Adjusted EBITDA $ 26,912 $ 24,272 $ 24,415 Adjusted EBITDA as a percentage of net sales 14.4 % 13.1 % 13.1 %


 
Sales Summary - Q2 FY2017 (Unaudited) 26


 
Cost Rationalization Drives Margin Improvement U.S. GAAP (Unaudited) 27


 
Cost Rationalization Drives Margin Improvement U.S. GAAP (Unaudited) 28 (1) Excluding write down of long-lived assets and restructuring charges of $10.2 million for the quarter ended September 30, 2016, operating margin would have been 5.4%. 5.4% (1)


 
Cost Rationalization Drives Margin Improvement Non-GAAP (Unaudited) 29


 
Quarterly Financial Summary Non-GAAP (Unaudited) 30


 
Annual Financial Summary Non-GAAP (Unaudited) CAPEX as a % of Revenue 3.8% 2.7% 2.7% 3.0% 31


 
Financial Highlights (Unaudited) (1) Calculated as accounts receivable, net, plus inventories, net, less accounts payable. (2) Current quarter's accounts receivable divided by annualized current quarter’s Net sales multiplied by 365. (3) Current quarter's accounts payable divided by annualized current quarter's cost of goods sold multiplied by 365. 32 (Amounts in millions, except DSO and DPO) Sep 2016 Jun 2016 Sep 2015 Cash, cash equivalents $ 74.8 $ 52.9 $ 37.3 Capital expenditures $ 4.2 $ 6.2 $ 3.5 Short-term debt $ — $ — $ 5.0 Long-term debt 386.9 386.9 388.0 Debt premium and issuance costs (0.8 ) (0.9 ) 2.1 Total debt $ 386.1 $ 386.0 $ 395.1 Net working capital (1) $ 189.0 $ 190.2 $ 206.7 Days in receivables (DSO)(2) 43 44 46 Days in payables (DPO)(3) 41 43 45


 
Financial Trends Cash and Cash Equivalents (Unaudited) 33 (in millions) * FY2017 Q3 and Q4 cash balances reflect the Company’s most recent estimates and exclude any impact of additional debt repurchases authorized by the Board. Actual operating results may vary.


 
NEC TOKIN UPDATE


 
• Since the beginning of the equity investment KEMET have had the intention of acquiring the remaining interest for a 100% stake. • Beginning in March 2014, NT was notified that it was being investigated by numerous government authorities for alleged antitrust violations dating back as early as 2002. The uncertain impact of the investigations and related civil litigation on NT’s financial results has caused a delay in KEMET’s completion of the NT acquisition. • Recent NT settlements with regulators and class-action plaintiffs have provided clarity and removed significant obstacles to the completion of the transaction. Several jurisdictions have yet to provide their conclusions. • KEMET and NEC remain in discussion concerning the terms of the acquisition. It is anticipated that the final structure and mechanics of this transaction will be announced with the completion of a definitive agreement. It may vary from the existing agreement between the parties. • Current expectation still remains a closing by the end of KEMET’s current fiscal year. NEC TOKIN Acquisition Update


 
• Predictable and consistent operating margins • Profitable (excluding restructuring items) • Reliable • Emotional favorite of our customers • Cash flow generation • Anticipating announcement of NEC TOKIN acquisition early 2017. SUMMARY


 
Follow KEMET 147,595 views 12,719 Likes 12,186 Followers 2,651 Followers


 
Appendix


 
Adjusted Gross Margin Non-GAAP (Unaudited) 39 For the Quarters Ended (Amounts in thousands, except percentages) Sep 2016 Jun 2016 Sep 2015 Net Sales $ 187,308 $ 184,935 $ 186,123 Gross Margin (U.S. GAAP) $ 46,413 $ 42,523 $ 42,806 Gross margin as a percentage of net sales 24.8 % 23.0 % 23.0 % Adjustments: Plant start-up costs 119 308 187 Stock-based compensation expense 301 384 459 Adjusted Gross margin (non-GAAP) $ 46,833 $ 43,215 $ 43,452 Adjusted gross margin as a percentage of net sales 25.0 % 23.4 % 23.3 %


 
Adjusted Selling, General & Administrative Expenses Non-GAAP (Unaudited) 40 For the Quarters Ended (Amounts in thousands, except percentages) Sep 2016 Jun 2016 Sep 2015 Net sales $ 187,308 $ 184,935 $ 186,123 Selling, general and administrative expenses (U.S. GAAP) $ 25,972 $ 25,914 $ 22,948 Selling, general, and administrative as a percentage of net sales 13.9 % 14.0 % 12.3 % Less adjustments: ERP integration/IT transition costs 1,783 1,768 282 Legal expenses related to antitrust class actions 766 1,175 541 NEC TOKIN investment-related expenses 194 206 186 Stock-based compensation expense 754 785 809 Adjusted selling, general and administrative expenses (non-GAAP) $ 22,475 $ 21,980 $ 21,130 Adjusted selling, general, and administrative as a percentage of net sales 12.0 % 11.9 % 11.4 %


 
Adjusted Operating Income (Loss) Non-GAAP (Unaudited) 41 For the Quarters Ended (Amounts in thousands) Sep 2016 Jun 2016 Sep 2015 Net sales $ 187,308 $ 184,935 $ 186,123 Operating income (loss) (U.S. GAAP) $ 3,050 $ 8,898 $ 13,987 Operating income (loss) as a percentage of net sales 1.6 % 4.8 % 7.5 % Adjustments: Write down of long-lived assets 6,193 — — Restructuring charges 3,998 688 23 Stock-based compensation expense 1,104 1,228 1,328 ERP integration/IT transition costs 1,783 1,768 282 Legal expenses related to antitrust class actions 766 1,175 541 Plant start-up costs 119 308 187 NEC TOKIN investment-related expenses 194 206 186 Net (gain) loss on sales and disposals of assets 84 91 (304 ) Adjusted operating income (loss) (non-GAAP) $ 17,291 $ 14,362 $ 16,230 Adjusted operating income (loss) as a percentage of net sales 9.2 % 7.8 % 8.7 %


 
Adjusted Net Income (Loss) Non-GAAP (Unaudited) 42 (1) The income tax effect of the excluded items is calculated by applying the applicable jurisdictional income tax rate, considering the deferred tax valuation for each applicable jurisdiction. For the Quarters Ended (Amounts in thousands) Sep 2016 Jun 2016 Sep 2015 Net sales $ 187,308 $ 184,935 $ 186,123 Net income (loss) (U.S. GAAP) $ (4,998 ) $ (12,205 ) $ 7,194 Net income (loss) as a percentage of net sales (2.7 )% (6.6 )% 3.9 % Adjustments: Write down of long-lived assets 6,193 — — Restructuring charges 3,998 688 23 ERP integration/IT transition costs 1,783 1,768 282 Change in value of NEC TOKIN option (1,600 ) 12,000 (2,200 ) Stock-based compensation expense 1,104 1,228 1,328 Legal expenses related to antitrust class actions 766 1,175 541 Net foreign exchange (gain) loss (724 ) (1,920 ) (3,171 ) NEC TOKIN investment-related expenses 194 206 186 Amortization included in interest expense 188 190 217 Equity (income) loss from NEC TOKIN (181 ) (223 ) (162 ) Plant start-up costs 119 308 187 Net (gain) loss on sales and disposals of assets 84 91 (304 ) Income tax effect of non-U.S. GAAP adjustments (1) 29 — 153 Adjusted net income (loss) (non-GAAP) $ 6,955 $ 3,306 $ 4,274 Adjusted net income (loss) as a percentage of net sales 3.7 % 1.8 % 2.3 % Adjusted net income (loss) per share - basic $ 0.15 $ 0.07 $ 0.09 Adjusted net income (loss) per share - diluted $ 0.13 $ 0.06 $ 0.09 Weighted avg. shares - basic 46,590 46,349 45,767 Weighted avg. shares - diluted 53,834 52,097 50,004


 
Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) 43 Quarter Ended LTM (Amounts in thousands, except percentages) Mar 2014 Jun 2014 Sep 2014 Dec 2014 Dec 2014 Net Sales $ 215,821 $ 212,881 $ 215,293 $ 201,310 $ 845,305 Net income (loss) (14,447 ) (3,540 ) 6,330 2,914 (8,743 ) Income tax expense (benefit) (2,811 ) 1,282 2,583 1,359 2,413 Interest expense, net 10,658 10,453 10,284 9,933 41,328 Depreciation and amortization 12,175 10,797 10,177 9,720 42,869 EBITDA 5,575 18,992 29,374 23,926 77,867 Excluding the following items (Non-GAAP): Change in value of NEC TOKIN options (1,777 ) (4,100 ) (6,600 ) (2,500 ) (14,977 ) Equity (gain) loss from NEC TOKIN 4,127 1,675 (232 ) (1,367 ) 4,203 Restructuring charges 5,954 1,830 1,687 6,063 15,534 ERP integration costs / IT transition costs 837 895 409 671 2,812 Stock-based compensation expense 579 994 958 1,232 3,763 Legal expenses related to antitrust class actions — — — 409 409 Net foreign exchange (gain) loss (449 ) 527 (1,351 ) (1,257 ) (2,530 ) NEC TOKIN investment-related expenses 618 580 487 485 2,170 Plant start-up costs 669 1,647 1,114 1,144 4,574 Plant shut-down costs 2,668 889 — — 3,557 Net (gain) loss on sales and disposals of assets (39 ) 365 (550 ) (574 ) (798 ) (Income) loss from discontinued operations (103 ) (6,943 ) 1,400 164 (5,482 ) (Gain) loss on early extinguishment of debt — — — (1,003 ) (1,003 ) Professional fees related to financing activities — — — 1,142 1,142 Inventory revaluation — 2,676 (821 ) (927 ) 928 Write down of long-lived assets 1,118 — — — 1,118 Infrastructure tax 1,079 — — — 1,079 Adjusted EBITDA $ 20,856 $ 20,027 $ 25,875 $ 27,608 $ 94,366 Adjusted EBITDA Margin 9.7 % 9.4 % 12.0 % 13.7 % 11.2 %


 
44 Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) Quarter Ended LTM (Amounts in thousands, except percentages) Sep 2014 Dec 2014 Mar 2015 Jun 2015 Jun 2015 Net Sales $ 215,293 $ 201,310 $ 193,708 $ 187,590 $ 797,901 Net income (loss) 6,330 2,914 (19,847 ) (37,050 ) (47,653 ) Income tax expense (benefit) 2,583 1,359 3 (248 ) 3,697 Interest expense, net 10,284 9,933 10,016 10,010 40,243 Depreciation and amortization 10,177 9,720 10,074 9,917 39,888 EBITDA 29,374 23,926 246 (17,371 ) 36,175 Excluding the following items (Non-GAAP): Change in value of NEC TOKIN options (6,600 ) (2,500 ) 11,100 29,200 31,200 Equity (gain) loss from NEC TOKIN (232 ) (1,367 ) 2,093 (1,585 ) (1,091 ) Restructuring charges 1,687 6,063 3,437 1,824 13,011 ERP integration costs / IT transition costs 409 671 1,273 4,369 6,722 Stock-based compensation expense 958 1,232 1,328 1,279 4,797 Legal expenses related to antitrust class actions — 409 435 718 1,562 Net foreign exchange (gain) loss (1,351 ) (1,257 ) (2,168 ) 1,049 (3,727 ) NEC TOKIN investment-related expenses 487 485 226 224 1,422 Plant start-up costs 1,114 1,144 651 195 3,104 Net (gain) loss on sales and disposals of assets (550 ) (574 ) 538 (58 ) (644 ) Pension plan adjustment — — — 312 312 (Income) loss from discontinued operations 1,400 164 — — 1,564 (Gain) loss on early extinguishment of debt — (1,003 ) — — (1,003 ) Professional fees related to financing activities — 1,142 — — 1,142 Inventory revaluation (821 ) (927 ) (928 ) — (2,676 ) Adjusted EBITDA $ 25,875 $ 27,608 $ 18,231 $ 20,156 $ 91,870 Adjusted EBITDA Margin 12.0 % 13.7 % 9.4 % 10.7 % 11.5 %


 
Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) 45 Quarter Ended LTM (Amounts in thousands, except percentages) Dec 2014 Mar 2015 Jun 2015 Sep 2015 Sep 2015 Net Sales $ 201,310 $ 193,708 $ 187,590 $ 186,123 $ 768,731 Net income (loss) 2,914 (19,847 ) (37,050 ) 7,194 (46,789 ) Income tax expense (benefit) 1,359 3 (248 ) 1,438 2,552 Interest expense, net 9,933 10,016 10,010 9,808 39,767 Depreciation and amortization 9,720 10,074 9,917 9,265 38,976 EBITDA 23,926 246 (17,371 ) 27,705 34,506 Excluding the following items (Non-GAAP): Change in value of NEC TOKIN options (2,500 ) 11,100 29,200 (2,200 ) 35,600 Equity (gain) loss from NEC TOKIN (1,367 ) 2,093 (1,585 ) (162 ) (1,021 ) Restructuring charges 6,063 3,437 1,824 23 11,347 ERP integration costs / IT transition costs 671 1,273 4,369 282 6,595 Stock-based compensation expense 1,232 1,328 1,279 1,328 5,167 Legal expenses related to antitrust class actions 409 435 718 541 2,103 Net foreign exchange (gain) loss (1,257 ) (2,168 ) 1,049 (3,171 ) (5,547 ) NEC TOKIN investment-related expenses 485 226 224 186 1,121 Plant start-up costs 1,144 651 195 187 2,177 Net (gain) loss on sales and disposals of assets (574 ) 538 (58 ) (304 ) (398 ) Pension plan adjustment — — 312 — 312 (Income) loss from discontinued operations 164 — — — 164 (Gain) loss on early extinguishment of debt (1,003 ) — — — (1,003 ) Professional fees related to financing activities 1,142 — — — 1,142 Inventory revaluation (927 ) (928 ) — — (1,855 ) Adjusted EBITDA $ 27,608 $ 18,231 $ 20,156 $ 24,415 $ 90,410 Adjusted EBITDA Margin 13.7 % 9.4 % 10.7 % 13.1 % 11.8 %


 
Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) 46 Quarter Ended LTM (Amounts in thousands, except percentages) Mar 2015 Jun 2015 Sep 2015 Dec 2015 Dec 2015 Net Sales $ 193,708 $ 187,590 $ 186,123 $ 177,184 $ 744,605 Net income (loss) (19,847 ) (37,050 ) 7,194 (8,600 ) (58,303 ) Income tax expense (benefit) 3 (248 ) 1,438 2,760 3,953 Interest expense, net 10,016 10,010 9,808 9,848 39,682 Depreciation and amortization 10,074 9,917 9,265 9,674 38,930 EBITDA 246 (17,371 ) 27,705 13,682 24,262 Excluding the following items (Non-GAAP): Change in value of NEC TOKIN options 11,100 29,200 (2,200 ) (700 ) 37,400 Equity (gain) loss from NEC TOKIN 2,093 (1,585 ) (162 ) 6,505 6,851 Restructuring charges 3,437 1,824 23 1,714 6,998 ERP integration costs / IT transition costs 1,273 4,369 282 167 6,091 Stock-based compensation expense 1,328 1,279 1,328 1,154 5,089 Legal expenses related to antitrust class actions 435 718 541 1,300 2,994 Net foreign exchange (gain) loss (2,168 ) 1,049 (3,171 ) (1,036 ) (5,326 ) NEC TOKIN investment-related expenses 226 224 186 225 861 Plant start-up costs 651 195 187 160 1,193 Plant shut-down costs — — — 231 231 Net (gain) loss on sales and disposals of assets 538 (58 ) (304 ) 129 305 Pension plan adjustment — 312 — — 312 Inventory revaluation (928 ) — — — (928 ) Adjusted EBITDA $ 18,231 $ 20,156 $ 24,415 $ 23,531 $ 86,333 Adjusted EBITDA Margin 9.4 % 10.7 % 13.1 % 13.3 % 11.6 %


 
47 Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) Quarter Ended LTM (Amounts in thousands, except percentages) Sep 2015 Dec 2015 Mar 2016 Jun 2016 Jun 2016 Net Sales $ 186,123 $ 177,184 $ 183,926 $ 184,935 $ 732,168 Net income (loss) 7,194 (8,600 ) (15,173 ) (12,205 ) (28,784 ) Income tax expense (benefit) 1,438 2,760 2,056 1,800 8,054 Interest expense, net 9,808 9,848 9,925 9,920 39,501 Depreciation and amortization 9,265 9,674 10,160 9,436 38,535 EBITDA 27,705 13,682 6,968 8,951 57,306 Excluding the following items (Non-GAAP): Change in value of NEC TOKIN options (2,200 ) (700 ) — 12,000 9,100 Equity (gain) loss from NEC TOKIN (162 ) 6,505 11,648 (223 ) 17,768 Restructuring charges 23 1,714 617 688 3,042 ERP integration costs / IT transition costs 282 167 859 1,768 3,076 Stock-based compensation expense 1,328 1,154 1,013 1,228 4,723 Legal expenses related to antitrust class actions 541 1,300 482 1,175 3,498 Net foreign exchange (gain) loss (3,171 ) (1,036 ) 122 (1,920 ) (6,005 ) NEC TOKIN investment-related expenses 186 225 265 206 882 Plant start-up costs 187 160 319 308 974 Plant shut-down costs — 231 141 — 372 Net (gain) loss on sales and disposals of assets (304 ) 129 608 91 524 Adjusted EBITDA $ 24,415 $ 23,531 $ 23,042 $ 24,272 $ 95,260 Adjusted EBITDA Margin 13.1 % 13.3 % 12.5 % 13.1 % 13.0 %


 
Quarter Ended LTM (Amounts in thousands, except percentages) Dec 2015 Mar 2016 Jun 2016 Sep 2016 Sep 2016 Net Sales $ 177,184 $ 183,926 $ 184,935 $ 187,308 $ 733,353 Net income (loss) (8,600 ) (15,173 ) (12,205 ) (4,998 ) (40,976 ) Income tax expense (benefit) 2,760 2,056 1,800 830 7,446 Interest expense, net 9,848 9,925 9,920 9,904 39,597 Depreciation and amortization 9,674 10,160 9,436 9,440 38,710 EBITDA 13,682 6,968 8,951 15,176 44,777 Excluding the following items (Non-GAAP): Change in value of NEC TOKIN options (700 ) — 12,000 (1,600 ) 9,700 Equity (gain) loss from NEC TOKIN 6,505 11,648 (223 ) (181 ) 17,749 Restructuring charges 1,714 617 688 3,998 7,017 ERP integration costs / IT transition costs 167 859 1,768 1,783 4,577 Stock-based compensation expense 1,154 1,013 1,228 1,104 4,499 Legal expenses related to antitrust class actions 1,300 482 1,175 766 3,723 Net foreign exchange (gain) loss (1,036 ) 122 (1,920 ) (724 ) (3,558 ) NEC TOKIN investment-related expenses 225 265 206 194 890 Plant start-up costs 160 319 308 119 906 Plant shut-down costs 231 141 — — 372 Net (gain) loss on sales and disposals of assets 129 608 91 84 912 Write down of long-lived assets — — — 6,193 6,193 Adjusted EBITDA $ 23,531 $ 23,042 $ 24,272 $ 26,912 $ 97,757 Adjusted EBITDA Margin 13.3 % 12.5 % 13.1 % 14.4 % 13.3 % Adjusted EBITDA Reconciliation Non-GAAP (Unaudited)


 
Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) 49 Fiscal Year (Amounts in thousands, except percentages) 2014 2015 2016 Net Sales $ 833,666 $ 823,192 $ 734,823 Net income (loss) (68,503 ) (14,143 ) (53,629 ) Income tax expense (benefit) 1,482 5,227 6,006 Interest expense, net 40,767 40,686 39,591 Depreciation and amortization 49,527 40,768 39,016 EBITDA 23,273 72,538 30,984 Excluding the following items (Non- GAAP): Change in value of NEC TOKIN options (3,111 ) (2,100 ) 26,300 Equity (gain) loss from NEC TOKIN 7,090 2,169 16,406 Restructuring charges 14,122 13,017 4,178 ERP integration costs / IT transition costs 3,880 3,248 5,677 Stock-based compensation expense 2,909 4,512 4,774 Legal expenses related to antitrust class actions — 844 3,041 Net foreign exchange (gain) loss (304 ) (4,249 ) (3,036 ) NEC TOKIN investment-related expenses 2,299 1,778 900 Plant start-up costs 3,336 4,556 861 Plant shut-down costs 2,668 889 372 Net (gain) loss on sales and disposals of assets 32 (221 ) 375 Pension plan adjustment — — 312 (Income) loss from discontinued operations 3,634 (5,379 ) — (Gain) loss on early extinguishment of debt — (1,003 ) — Professional fees related to financing activities — 1,142 — Write down of long-lived assets 4,476 — — Inventory write-downs 3,886 — — Long-term receivable write down 1,444 — — Infrastructure tax 1,079 — — Adjusted EBITDA $ 70,713 $ 91,741 $ 91,144 Adjusted EBITDA Margin 8.5 % 11.1 % 12.4 %


 
Non-GAAP Financial Measures Non-GAAP Financial Measures Included in this presentation are certain non-GAAP financial measures designed to complement the financial information presented in accordance with generally accepted accounting principles in the United States of America because management believes such measures are useful to investors for the reasons described below. Adjusted gross margin Adjusted gross margin represents net sales less cost of sales excluding adjustments which are outlined in the quantitative reconciliation provided earlier in this presentation. Management uses Adjusted gross margin to facilitate our analysis and understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided earlier in this presentation which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that Adjusted gross margin is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company. Adjusted gross margin should not be considered as an alternative to gross margin or any other performance measure derived in accordance with GAAP. Adjusted selling, general and administrative expenses Adjusted selling, general and administrative expenses represents selling, general and administrative expenses excluding adjustments which are outlined in the quantitative reconciliation provided earlier in this presentation. Management uses Adjusted selling, general and administrative expenses to facilitate our analysis and understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided earlier in this presentation which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that Adjusted selling, general and administrative expenses is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company. Adjusted selling, general and administrative expenses should not be considered as an alternative to selling, general and administrative expenses or any other performance measure derived in accordance with GAAP. 50


 
Non-GAAP Financial Measures Continued Adjusted operating income (loss) Adjusted operating income (loss) represents operating income (loss), excluding adjustments which are outlined in the quantitative reconciliation provided earlier in this presentation. Management uses Adjusted operating income to facilitate our analysis and understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided earlier in this presentation which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that Adjusted operating income is useful to investors to provide a supplemental way to understand the underlying operating performance of the Company and monitor and understand changes in our ability to generate income from ongoing business operations. Adjusted operating income should not be considered as an alternative to operating loss or any other performance measure derived in accordance with GAAP. Adjusted net income (loss) and Adjusted EPS Adjusted net income (loss) and Adjusted EPS represent net income (loss) and EPS, excluding adjustments which are more specifically outlined in the quantitative reconciliation provided earlier in this presentation. Management uses Adjusted net income (loss) and Adjusted EPS to evaluate the Company's operating performance by excluding the items outlined in the quantitative reconciliation provided earlier in this presentation which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that Adjusted net income (loss) and Adjusted EPS are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company and allows investors to monitor and understand changes in our ability to generate income from ongoing business operations. Adjusted net income (loss) and Adjusted EPS should not be considered as alternatives to net income, operating income or any other performance measures derived in accordance with GAAP. 51


 
Non-GAAP Financial Measures Continued Adjusted EBITDA Adjusted EBITDA represents net loss before income tax expense (benefit), interest expense, net, and depreciation and amortization expense, excluding adjustments which are more specifically outlined in the quantitative reconciliation provided earlier in this presentation. We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt. We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry. We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity, because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other items excluded from Adjusted EBITDA are excluded in order to better reflect our continuing operations. In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments. Adjusted EBITDA is not a measurement of our financial performance under GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity. 52


 
Non-GAAP Financial Measures Continued Our Adjusted EBITDA measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are: • it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments; • it does not reflect changes in, or cash requirements for, our working capital needs; • it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt; • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements; • it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows; • it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations; • it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and • other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure. Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only supplementally. 53


 


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings